Skip to main content
. 2022 Jun 10;13:927153. doi: 10.3389/fimmu.2022.927153

Figure 2.

Figure 2

Potential therapeutic targets in hematological malignancies. A variety of attractive targets for CAR-T cell therapy in hematological malignancies, including T and B cell leukemia/lymphoma, HL, AML, and MM.